$36.82
0.280.77%
At close: -
$36.82
0.000.00%
After Hours: Jan 17, 4:00 PM EDT
Comments
Loading...
Protagonist Therapeutics (NASDAQ:PTGX) Stock, Earnings Estimates, EPS, And Revenue
Protagonist Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 25
EPS Estimate
$1.030
Quarterly Revenue Estimate
$53.52M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$323.80M
Analyze the earnings history of Protagonist Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Protagonist Therapeutics (PTGX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.54 | $-0.63 | 14.3 % |
| Q2 | 2024-08-06 | $-0.50 | $-0.60 | 16.7 % |
| Q1 | 2024-05-07 | $3.26 | $2.51 | 29.9 % |
| Q4 | 2024-02-27 | $0.44 | $-0.03 | 1566.7 % |
Protagonist Therapeutics (PTGX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $4.68M | $2.07M | 125.7 % |
| Q2 | 2024-08-06 | $4.17M | $8.00M | -47.9 % |
| Q1 | 2024-05-07 | $254.95M | $120.00M | 112.5 % |
| Q4 | 2024-02-27 | $60.00M | $40.00M | 50.0 % |
FAQ
When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?
Protagonist Therapeutics (PTGX) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Protagonist Therapeutics (NASDAQ:PTGX)?
The Actual EPS was $-0.54, which beat the estimate of $-0.63.
What were Protagonist Therapeutics’s (NASDAQ:PTGX) revenues?
The Actual Revenue was $4.7M, which beat the estimate of $2.1M.
Browse earnings estimates, EPS, and revenue on all stocks.